Harrow, Inc. (HROW)
(Delayed Data from NSDQ)
$43.57 USD
-0.40 (-0.91%)
Updated Sep 17, 2024 03:59 PM ET
After-Market: $43.58 +0.01 (0.02%) 7:16 PM ET
3-Hold of 5 3
D Value C Growth F Momentum D VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 29% (72 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.58 | 9.99 |
Current Quarter Estimate | -0.01 | -1.17 | 61.00 |
Year Ago Quarter Estimate | -0.09 | -0.06 | 54.84 |
Next Quarter Estimate | 0.30 | -1.92 | 63.00 |
Next Year Estimate | 0.97 | 12.59 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 40.91 | 20.20 | 15.67 |
Next Year | 348.72 | 15.30 | 11.34 |
Last 5 Years | -201.20 | 7.90 | 8.10 |
Next 5 Years | NA | 20.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -1.44 |
Price/Book (MRQ) | 26.74 | 1.59 |
Price/Cash Flow (MRFY) | NA | 9.47 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -21.78% | -61.35% |
Return on Equity (TTM) | -40.59% | -58.93% |
Debt to Equity (MRQ) | 3.18 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.